An Exploratory Study on Developing an Integrated Approach Combining Multimodal Imaging and Multi-omics Characterization of Tumor Heterogeneity for Precision Diagnosis and Treatment Optimization in Liver Cancer.
Recruiting
Observational Study
Hepatocellular Carcinoma (HCC)
Intrahepatic Cholangiocarcinoma (ICC)
Primary Liver Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Study type
- Observational
- Participants needed
- 308 (estimated)
- Sponsor
- Peking Union Medical College Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Primary liver cancer, mainly including hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC), represents the third leading cause of cancer-related mortality. Enhancing the precision of liver cancer diagnosis and providing early therapeutic efficacy and prognostic evaluation during clinical decision-making hold significant clinical importance. Ultrasound is the preferred imaging …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Age \>18 and ≤70 years;
2. Both sexes eligible;
3. Diagnosed with primary HCC or ICC;
4. Scheduled for surgical resection or conversion therapy;
5. Pathologically confirmed HCC/ICC via surgery or biopsy;
6. Posterior margin of the lesion ≤ 8 cm from the skin surface.
Exclusi…
Contacts